Case File
efta-01880337DOJ Data Set 10OtherEFTA01880337
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01880337
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
From:
e reyEpstein
Sent:
Thur 6/7/2012 4:01:56 PM
Subject: Re: Fw:
call-
On Thu, Jun 7, 2012 at 9:43 AM, wrote:
Sent via BlackBerry from T-Mobile
Original Message----
From: Joshua Fink <[email protected]>
Date: Thu, 7 Jun 2012 11:12:52
To: '[email protected]'[email protected]>
Cc:
Subject: RE:
Dear Jean Luc,
I am not sure if you received the email I sent on Tuesday. By chance yesterday I received an
invoice from MC2 in the mail. I would love to clarify a point or two with you as I do not
believe I have a full understanding of things at the moment. I am more than happy to pay this
invoice if our agreement still stands and there is no issue from my side if that is the case.
Thank you in advance for your time and look forward to meeting and speaking soon.
Warmest regards,
Josh
Original Message
From: Joshua Fink
Sent: Tuesday, June 05, 2012 10:16 PM
To: '[email protected]
Cc:
Subject:
Dear Jean Luc,
I hope this email finds you well. I would love to grab a bite or a drink if you are through nyc in
the next week. Alternatively, are you available for a quick phone call tomorrow? Thank you
very much.
Warmest regards,
Josh
EFTA_R1_00292569
EFTA01880337
Joshua Fink
CEO & Chief Investment Officer
Enso Capital Management LLC
This e-mail and any attachments thereto, is intended only for use by the addressee(s) named
herein and may contain legally privileged and/or confidential information. If you are not the
intended recipient of this e-mail, you are hereby notified any dissemination, distribution or
copying of this email, and any attachments thereto, is strictly prohibited. If you receive this
email in error please immediately notify us at and permanently delete the
original copy and any copy of any e-mail, and any printout thereof. Further information about
the firm, a list of the Partners and their professional qualifications will be provided upon
request.
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please noti us immediate) by
return e-mail or by e-mail t and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00292570
EFTA01880338
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.